Michael studied Biochemistry in Oxford (Univ) before undertaking his doctoral studies at the Sir William Dunn School of Pathology. His work in the laboratories of Dr. Eva Gluez and Prof. Keith Gull was focussed on the transcriptome of the protozoan parasite Leishmania mexicana. Upon completing his DPhil, Michael joined Absolute Antibody, an Oxford-based biotech company specialising in sequencing, engineering and recombinant expression of antibodies. As their Product Development Manager he is responsible for a range of tasks from identifying new products for Absolute Antibody’s catalogue, in-licensing negotiations to helping customers identify which products are most suitable for their research.
Departmental Contact email@example.com